Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04480060
Recruitment Status : Completed
First Posted : July 21, 2020
Last Update Posted : July 21, 2020
Sponsor:
Information provided by (Responsible Party):
Ramazan Guven, Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary:
COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Emergency departments also carried out an important part of the fight against pandemics in our country/Turkey. The emergency department including an intensive care unit is very few in this country/Turkey and the only hospital, which has an Emergency Intensive Care Unit (EICU) in Istanbul, is the study center. Therefore, this retrospective study aimed to provide useful information about how an effective EICU should be, especially how to use them during pandemic periods.

Condition or disease Intervention/treatment
Covid19 Diagnostic Test: COVID-19 diagnostic PCR

Detailed Description:
COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. Emergency departments also carried out an important part of the fight against pandemics in our country/Turkey. The emergency department including an intensive care unit is very few in this country/Turkey and the only hospital, which has an Emergency Intensive Care Unit (EICU) in Istanbul, is the study center. Throughout the pandemic, many patients, including COVID-19 patients, were successfully followed up and discharged from EICU. With this study, the investigators expect to show the role of EICU during the pandemic. In addition, it will be seen that whether the patients, who are waiting for hospitalization or waiting for referral, are admitted to EICU faster and their treatments will be started promptly. Therefore, this retrospective study aimed to provide useful information about how an effective EICU should be, especially how to use them during pandemic periods.

Layout table for study information
Study Type : Observational
Actual Enrollment : 100000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic: Retrospective Cohort Study
Actual Study Start Date : March 10, 2020
Actual Primary Completion Date : June 30, 2020
Actual Study Completion Date : July 14, 2020

Intervention Details:
  • Diagnostic Test: COVID-19 diagnostic PCR
    Nasopharyngeal swab samples will be analyzed by PCR for COVID-19 DNA existence.


Primary Outcome Measures :
  1. Mortality of the COVID-19 patients [ Time Frame: 3 months ]
    Mortality of the COVID-19 patients who followed up by emergency department ICU



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
All patients who followed up in emergency department ICU's of study centers with the diagnosis of COVID-19
Criteria

Inclusion Criteria:

  • All patients who followed up in emergency department ICU with the diagnosis of COVID-19
  • Accepted to participate with an informed consent

Exclusion Criteria:

  • Patients under the age of 18 or more than 50 years
  • declined to participate
  • deaths caused by other than COVID-19

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04480060


Locations
Layout table for location information
Turkey
Seda Yilmaz Semerci
Istanbul, Turkey, 34303
Sponsors and Collaborators
Kanuni Sultan Suleyman Training and Research Hospital
Layout table for additonal information
Responsible Party: Ramazan Guven, Professor, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier: NCT04480060    
Other Study ID Numbers: KSSEAH--EDCC
First Posted: July 21, 2020    Key Record Dates
Last Update Posted: July 21, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes